Decibel Therapeutics to Present at the 44th Annual ARO Conference [DB-OTO gene therapy] February 19, 2021https://ir.decibeltx.com/news-releases/news-release-details/decibel-therapeutics-present-44th-annual-association-research Decibel Therapeutics to Present at the 44th Annual Association for Research in Otolaryngology (ARO) Conference
Decibel and Catalent Sign Development and Manufacturing Agreement for Dual-Vector Gene Therapy for the Treatment of Hearing Loss February 4, 2021https://www.catalent.com/catalent-news/decibel-and-catalent-sign-development-and-manufacturing-agreement-for-dual-vector-gene-therapy-for-the-treatment-of-congenital-hearing-loss/ Decibel and Catalent Sign Development and Manufacturing Agreement for Dual-Vector Gene Therapy for the Treatment of Hearing Loss